Health Technology Assessment (HTA)

Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.

395 - 2014 Can-the-US-Afford-Chambers-2014-BIG
Publication

Can the US Afford to Ignore Cost-effectiveness Evidence?

1 March 2014

Cost-effectiveness analysis plays a limited role in US health care compared to many other countries. In this Seminar Briefing, Dr James Chambers, Center for the Evaluation…

Cracks through the ice on a melting glacier in Alaska
News

Inconsistent Use of Cost-effectiveness Thresholds in NHS Scotland

12 December 2013

This study finds an apparent mismatch in the decision making approaches of the SMC and the NHS Boards. OHE today released a Research Paper on the…

Cracks through the ice on a melting glacier in Alaska
News

Using MCDA to Assess the Value of Treatments for Rare Diseases

5 December 2013

A pilot study demonstrated the value of involving a range of stakeholders in MCDA for rare disease therapies. According to a study just published by the…

OHE's Health Outcomes Group
News

OHE Consulting Offers New Services in Patient-Reported Outcomes

4 December 2013

OHE Consulting is now offering our clients advice and analytical services on health outcomes and the use of patient-reported outcomes (PRO) data, building on the extensive…

Cracks through the ice on a melting glacier in Alaska
News

Mike Herdman Appointed as OHE’s Head of Health Outcomes

25 November 2013

OHE’s extensive expertise in health outcomes will be further enhanced with the addition of Mike. OHE is delighted to announce the appointment of Mike Herdman as…

Cracks through the ice on a melting glacier in Alaska
News

NICE Decisions: Cost-effectiveness is the Most Significant Predictor

21 November 2013

Using data for 1999-2011, this thorough analysis explores what has most influenced NICE’s decisions and whether this has changed. Established in 1999, the National Institute for…

Economic Incentives for Evidence Generation: Promoting an Efficient Path to Personalized Medicine
News

Personalised Medicine: Economic Incentives for Evidence Generation

28 October 2013

Four types of economic incentives for drugs and diagnostics are essential to encouraging more rapid progress in personalised medicine. Adrian Towse, OHE’s Director, and Lou Garrison,…

Health Economics: An Introduction to Economic Evaluation
News

Third Edition of OHE’s Guide to Health Economic Evaluation Released

12 September 2013

OHE today released the third edition of its popular primer, Health Economics: An Introduction to Economic Evaluation, authored by Gisela Kobelt, who has extensive hands-on experience…

Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation
News

ISPOR Task Force Report on Performance-Based Risk-Sharing Arrangements

28 August 2013

Best practices for performance-based risk-sharing arrangements in health care are described in detail in this new ISPOR report, developed by a task force co-chaired by Professor…